The Hempshire Group, Inc. (HMPSF)
Stock analysis · OTC · Healthcare · Drug Manufacturers - Specialty & Generic
$0.19
Market Cap
$15.68M
PE (TTM)
-1.97
EPS (TTM)
N/A
Dividend Yield
0.00%
Beta
0.12
Day Range
$0.19 – $0.20
52-wk Range
$0.19 – $0.20
Avg Volume
N/A
Volume
51.84K
The Hempshire Group, Inc. (HMPSF) is a publicly traded company in the Healthcare sector. Latest price: $0.19. Market cap $15.68M. Trailing PE -1.97. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →Proprietary Signals
About The Hempshire Group, Inc.
The Hempshire Group, Inc. specializes in the full lifecycle of pharmaceutical-grade hemp and CBD products, encompassing their acquisition, production, branding, and refinement. Established in 2019, this company operates from its base in Palm Springs, California.
Valuation
| P/E (TTM) | -1.97× |
|---|---|
| P/S (TTM) | 176.05× |
| P/B | 12.83× |
| P/FCF (TTM) | -5.10× |
| EV / EBITDA | -2.49× |
| EV / Sales | 173.51× |
| Earnings Yield | -50.84% |
| Free Cash Flow Yield | -19.59% |
Fundamentals
| Enterprise Value | $15.45M |
|---|---|
| Revenue (TTM) | $89.07K |
| Net Income (TTM) | -$7.97M |
| Free Cash Flow (TTM) | -$2.83M |
| Net Debt | -$226.33K |
| Working Capital | $658.92K |
| Gross Margin | 28.77% |
| Operating Margin | -2854.97% |
| Net Margin | -7300.91% |
| Return on Equity | -8060.99% |
| Return on Invested Capital | -253.12% |
Peers
Recent News
- No recent news available.
Related
Browse more tickers: sitemap